San Francisco-based Hinge Health has completed a randomized control trial of its digital care program for chronic knee pain. Results were promising, with users of the digital platform outperforming the control group in every outcome measure, though there was some loss of engagement among the study group.
“It was really strong results,” CEO Daniel Perez told MobiHealthNews. “It was a trial that...
San Francisco and London-based Hinge Health, which makes a scalable digital health program for treating musculoskeletal (MSK) conditions, has raised $8 million in a new round of funding led by Atomico. All the company’s seed investors, including Eleven Two Capital and The Vertical Group, also participated in the round.
Hinge Health is using digital health technology, including wearables and apps...
